Doravirine, lamivudine, and tenofovir disoproxil fumarate

DELSTRIGO is a prescription medication combining doravirine (100 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg) in an oral tablet. It's used to treat HIV-1 infection in adults and children weighing at least 35 kg, working by inhibiting the virus's ability to replicate. Marketed by Merck Sharp & Dohme LLC since 2018. This information was generated using AI and is provided for informational and research purposes only.